Refreshing results…
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
UploadPairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML
UploadMissing publications? Search for publications with a matching author name.